Ipamorelin vs Orforglipron
Overview
Ipamorelin is primarily a performance & growth peptide, while Orforglipron is used for weight management & metabolic.
This page compares Ipamorelin and Orforglipron across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Ipamorelin | Orforglipron | |
|---|---|---|
| Category | Performance & Growth | Weight Management & Metabolic |
| Regulatory status (US) | Research use only | FDA approved |
| Typical dosage | 200-300 mcg | Clinical trials |
| Frequency | twice-daily | daily |
| Reported benefits | Natural GH release, improved body composition, better sleep, anti-aging effects, no appetite increase | Oral administration convenience, weight loss, glucose control |
| Reported side effects | Very well-tolerated. Rare: headache, injection site reactions | Under investigation |
Key differences
Primary use. Ipamorelin is categorised under Performance & Growth, while Orforglipron falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Ipamorelin: not FDA-approved; treated as a research compound. Orforglipron: FDA-approved.
Dosing. Ipamorelin is typically dosed at 200-300 mcg (twice-daily). Orforglipron is typically dosed at Clinical trials (daily).
Can you stack them?
Some protocols combine peptides, but stacking Ipamorelin and Orforglipron has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Ipamorelin and Orforglipron?
- Ipamorelin is primarily a performance & growth peptide, while Orforglipron is used for weight management & metabolic. Ipamorelin is not FDA-approved; generally classified as a research compound, whereas Orforglipron is FDA-approved for one or more indications.
- What is Ipamorelin used for?
- GH secretagogue, anti-aging.
- What is Orforglipron used for?
- Oral GLP-1.
- Can you take Ipamorelin and Orforglipron together?
- Some users combine peptides within a single protocol, but stacking Ipamorelin and Orforglipron has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Ipamorelin or Orforglipron FDA-approved?
- Ipamorelin is not FDA-approved; generally classified as a research compound. Orforglipron is FDA-approved for one or more indications.
Read the full articles
- Ipamorelin — full monograph: mechanism, research, dosing & references
- Orforglipron — full monograph: mechanism, research, dosing & references